FINGOLIMOD HYDROCHLORIDE vs GILENYA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Attribute	FINGOLIMOD HYDROCHLORIDE	GILENYA
Rating	72/100	70/100
Pharmacy pays	~$126.02 /30	~$126.02 /30
Type	RX	RX
Active ingredient	FINGOLIMOD HYDROCHLORIDE	FINGOLIMOD HYDROCHLORIDE
Manufacturer	Alembic	Novartis
Dosage forms	Capsule	Capsule
Drug class	Sphingosine 1-Phosphate Receptor Modulator	Sphingosine 1-Phosphate Receptor Modulator
Boxed warning	None	None
Half-life	about 6 to 9 days (average apparent terminal half-life)	about 6 to 9 days (average apparent terminal half-life)
Treats	Relapsing-Remitting Multiple Sclerosis	Relapsing-Remitting Multiple Sclerosis

fingolimod hydrochloride gilenya

Rating

72/100

70/100

Pharmacy pays

~$126.02 /30

Type

Active ingredient

FINGOLIMOD HYDROCHLORIDE

Manufacturer

Alembic

Novartis

Dosage forms

Capsule

Drug class

Sphingosine 1-Phosphate Receptor Modulator

Boxed warning

None

Half-life

about 6 to 9 days (average apparent terminal half-life)

Treats

Relapsing-Remitting Multiple Sclerosis

Frequently asked questions

Which is better-rated, Fingolimod Hydrochloride or Gilenya?

By our independent rating, Fingolimod Hydrochloride scores higher — 3.6 vs 3.5 out of 5 for Gilenya. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Fingolimod Hydrochloride or Gilenya?

Pharmacies pay about the same to acquire either one — roughly $126.02 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Fingolimod Hydrochloride and Gilenya?

Both Fingolimod Hydrochloride and Gilenya share the active ingredient Fingolimod Hydrochloride.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.